Showing results (151-160 of 162) with videos related to
Sort By:
Pageof 17
The Journal of Biological Chemistry|December 22, 2012
Ablation of calcineurin Aβ reveals hyperlipidemia and signaling cross-talks with phosphodiesterasesHee Yun Suk, Chen Zhou, Teddy T C Yang, et al.Cell|May 13, 2014
A proliferative burst during preadolescence establishes the final cardiomyocyte numberNawazish Naqvi, Ming Li, John W Calvert, et al.Biorxiv : the Preprint Server for Biology|November 19, 2025
Low Dose GLP-1 Therapy Attenuates Pathological Cardiac and Hepatic Remodelling in HFpEF Independent of Weight LossMahmoud H Elbatreek, Zhen Li, Xiaoman Yu, et al.American Journal of Physiology. Heart and Circulatory Physiology|January 20, 2018
Guidelines for experimental models of myocardial ischemia and infarctionMerry L Lindsey, Roberto Bolli, John M Canty, et al.Journal of the American College of Cardiology|June 15, 2019
Renal Denervation Update From the International Sympathetic Nervous System Summit: JACC State-of-the-Art ReviewMárcio G Kiuchi, Murray D Esler, Gregory D Fink, et al.Molecular and Cellular Biology|July 22, 2010
Evolutionarily conserved role of calcineurin in phosphodegron-dependent degradation of phosphodiesterase 4DHong Zhu, Hee Yun Suk, Raymond Y L Yu, et al.Nature Communications|December 31, 2024
Alcohol-induced gut microbial reorganization and associated overproduction of phenylacetylglutamine promotes cardiovascular diseaseZhen Li, Min Gu, Aline Zaparte, et al.Biorxiv : the Preprint Server for Biology|January 7, 2025
Dysregulation of Nitrosylation Dynamics Promotes Nitrosative Stress and Contributes to Cardiometabolic Heart Failure with Preserved Ejection FractionZhen Li, Kyle B LaPenna, Natalie D Gehred, et al.Circulation Research|September 17, 2025
Dysregulated Protein s-Nitrosylation Promotes Nitrosative Stress and Disease Progression in Heart Failure With Preserved Ejection FractionZhen Li, Kyle B LaPenna, Natalie D Gehred, et al.JACC. Basic to Translational Science|August 7, 2025
Hydrogen Sulfide Deficiency and Therapeutic Targeting in Cardiometabolic HFpEF: Evidence for Synergistic Benefit With GLP-1/Glucagon AgonismJake E Doiron, Mahmoud H Elbatreek, Huijing Xia, et al.Pageof 17